Archive

Britain's Neonatal Machines and the Fragile Economics of Life Sciences Growth

A small Sussex manufacturer's export slowdown exposes the gap between Whitehall's life sciences ambitions and the commercial reality facing the firms it depends on

Distilled Post Editorial Team

The Skinny Jab Seizure Reveals a Market the NHS Helped Create

A £200,000 asset freeze under the Proceeds of Crime Act exposes how far demand for weight-loss drugs has outrun the system meant to supply them safely

Distilled Post Editorial Team

Toxicity Is a Trajectory, Not a Grade

Why haematology needs to measure what treatment asks of patients over time

Distilled Post Editorial Team

The Big Stand Off: Sir Jim Mackey and Sam Jones

As the national health service prepares to be absorbed into the Department of Health, a quiet struggle is underway over whether it will retain its operational independence or yield to direct government control.

Distilled Post Editorial Team

A County's Books Reveal the NHS's Real Reckoning

Kent and Medway's restructuring is not a local accounting story. It is a preview of what "financial grip" now means across the health service.

Distilled Post Editorial Team

The Price Of Winning Pharma Back

A £2 billion investment surge shows industry confidence returning to Britain, but the same reforms driving it will also raise medicines spending across the NHS

Distilled Post Editorial Team

Public Mistrust in US Tech Firm Threatens Health Data Strategy

A surge in patients opting out of medical data sharing has prompted the government to reconsider the mandatory rollout of Palantir's controversial new software

Distilled Post Editorial Team

Private Equity Buys Into the NHS's Safety Valve

The £1.03 billion takeover of Spire Healthcare exposes how dependent the public system has become on capacity it does not own

Distilled Post Editorial Team